Close
#IOTSWC23

Vincent Uyttendaele

Founder - CEO | Insilicare Liège, Belgium
Vincent Uyttendaele

Biography

Graduated as a PhD in biomedical engineering from the university of Canterbury (New Zealand) and the university of Liège (Belgium), I focus on the development of digital twins and in-silico trials for the intensive care. More specifically, at Insilicare, we are currently developing a clinical support software for glycemic control using a unique patient-specific and risk-based approach to safely and effectively guide care.

Sessions

16:30h
Parallel Session | IOT Solutions World Congress Digital Twin Healthcare

Digital Twins to Improve Clinical Care

Vincent Uyttendaele
Vincent Uyttendaele Insilicare Founder - CEO Speaker

#Digital Twin, #Healthcare

31-01-2023 16:30 31-01-2023 17:00 Europe/Madrid Digital Twins to Improve Clinical Care

In medicine, the concept of digital twin is used to describe the use of individual-specific computer models for the prevention, prediction, diagnosis and treatment of a disease, as well as the optimization and personalization of intervention options. It provides a patient-specific means to answer therapeutic questions, from the discovery of new therapies to the prediction of the effect of a proposed therapeutic intervention and optimization of care. This session will explore how digital twins can improve healthcare and the main hurdles to their development and acceptance. Learn how digital twins can directly benefit patients by allowing for personalized treatment.

Room 3
Tue 31 16:30h - 17:00h Room 3

Pedro Mier

Pedro Mier holds a degree in Telecommunications Engineer ing from the Polytechnic University of Catalonia, MBA from ESADE and PADE from IESE. He is currently President of AMETIC (Association of Electronics, Information Technology and Telecommunications Companies of Spain), Shareholder and Chairman of the Board of Directors of TRYO Aerospace & Electronics, Board Member of the Premo Group and Committee of CTTC. member of Space Angels Network and Member of the Sc ientific Advisory

Close